biopsy is the most under-discussed thing in c/bloodwork
Something I noticed reading old threads that I have not seen said out loud.
The advice on hepatic fat in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
Sceptical. If this were true we would see it reflected in the data and we do not.
the safety profile is not just tirzepatide amplified
The constipation was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
the MASH indication changes the risk calculus
Yeah, glucagon co-agonism is genuinely different.
Yeah, glucagon co-agonism is genuinely different.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the GLP-1/glucagon dual is glucagon, different from GIP/GLP-1
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
phase 11 data is interesting, phase 25 will be different
I am going to push back on this slightly.
phase 16 data is interesting, phase 24 will be different
phase 16 data is interesting, phase 24 will be different
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
rodent dual agonist is investigation only
glucagon co-agonism has a different safety story
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
the heart rate signal is real in the data
Yeah, glucagon co-agonism is genuinely different.
Retitled to remove editorialising. Put the evidence in the body.
the MASH indication changes the risk calculus
glucagon co-agonism has a different safety story
Phase 16 or 33?
That is net peptide content, not purity. Different number, different meaning.
- 1phase 16 data is interesting, phase 24 will be different15 comments in this branch · started by u/marisol_frisk
- 2The constipation was genuinely awful for three weeks and then simply…6 comments in this branch · started by u/rania_marchand